Concord Biotech Limited (BOM:543960)
India flag India · Delayed Price · Currency is INR
1,807.00
-1.65 (-0.09%)
At close: Jul 11, 2025

Concord Biotech Revenue

In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B INR with 18.01% growth. Concord Biotech had revenue of 4.30B in the quarter ending March 31, 2025, with 34.77% growth.

Revenue
12.00B
Revenue Growth
+18.01%
P/S Ratio
15.72
Revenue / Employee
8.72M
Employees
1,377
Market Cap
188.65B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Mar 31, 2025 12.00B 1.83B 18.01%
Mar 31, 2024 10.17B 1.64B 19.20%
Mar 31, 2023 8.53B 1.40B 19.67%
Mar 31, 2022 7.13B 959.91M 15.56%
Mar 31, 2021 6.17B 1.05B 20.42%
Mar 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,646.93B
HDFC Bank 2,728.47B
Tata Consultancy Services 2,561.48B
Bharti Airtel 1,729.85B
ICICI Bank 2,006.54B
State Bank of India 3,429.39B
Infosys 1,647.16B
Hindustan Unilever 631.21B
Revenue Rankings